Reduced expression of MEK6 has been observed in several cancers, with its mechanism related to subsequent decreased activity of p38 and later p53, with reduced p53-mediated apoptosis and unchecked cell cycle inhibition [90]. The gene discussed is TP53; the disease is cancer.